Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1062 | 994 | 1125 | 1075 | 1322 | 1971 |
Fund Return | 6.22% | -0.55% | 12.47% | 2.44% | 5.74% | 7.02% |
Place in category | 1522 | 1598 | 1549 | 1017 | 480 | 98 |
% in Category | 99 | 100 | 100 | 76 | 42 | 14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Glbl Bal Priv Trust Sr F | 3.55B | 7.12 | 3.48 | 8.11 | ||
Manulife Glbl Bal Priv Trust Sr C | 3.55B | 7.14 | 3.50 | 8.13 | ||
Manulife Glbl Bal Priv Trust Sr CT6 | 3.55B | 7.13 | 3.48 | 8.12 | ||
Manulife Glbl Bal Priv Trust Sr FT6 | 3.55B | 7.12 | 3.48 | 8.12 | ||
Manulife Glbl Bal Priv Trust Sr T6 | 3.55B | 6.23 | 2.51 | 7.04 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RBC Sel Bal Port Sr F | 58.06B | 12.90 | 4.44 | 6.85 | ||
RBC Sel Bal Port Sr A | 58.06B | 11.98 | 3.42 | 5.80 | ||
CI Signature Glbl Incm Grwth A | 9.56B | 12.59 | 3.57 | 6.47 | ||
CI Signature Glbl Incm Grwth F | 9.56B | 13.64 | 4.73 | 7.66 | ||
Fidelity Global Bal Cl Port Sr F5 | 5.24B | 15.78 | 5.93 | 7.52 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Manulife Cdn Bond Adv | - | 17.29 | - | - | |
Manulife Global Unconstrained Bond Adv | - | 17.12 | - | - | |
Publicis Groupe | FR0000130577 | 3.19 | 102.45 | +2.14% | |
Marsh McLennan | US5717481023 | 2.97 | 227.82 | +1.52% | |
UnitedHealth | US91324P1021 | 2.53 | 590.87 | -1.11% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review